Blood pressure reduction in diabetes: lessons from ACCORD, SPRINT and EMPA-REG OUTCOME
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Blood pressure reduction in diabetes: lessons from ACCORD, SPRINT and EMPA-REG OUTCOME
Authors
Keywords
-
Journal
Nature Reviews Endocrinology
Volume 13, Issue 6, Pages 365-374
Publisher
Springer Nature
Online
2017-01-20
DOI
10.1038/nrendo.2016.209
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Importance of sustained and “tight” blood pressure control in patients with high cardiovascular risk
- (2016) Peter A. Meredith et al. BLOOD PRESSURE
- SGLT2 Inhibitors and Cardiovascular Risk: Lessons Learned From the EMPA-REG OUTCOME Study
- (2016) Muhammad Abdul-Ghani et al. DIABETES CARE
- CV Protection in the EMPA-REG OUTCOME Trial: A “Thrifty Substrate” Hypothesis
- (2016) Ele Ferrannini et al. DIABETES CARE
- Sodium-glucose cotransporter-2 inhibition for the reduction of cardiovascular events in high-risk patients with diabetes mellitus
- (2016) Nikolaus Marx et al. EUROPEAN HEART JOURNAL
- Hypertension Guidelines
- (2016) Rhian M. Touyz et al. HYPERTENSION
- Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
- (2016) NEW ENGLAND JOURNAL OF MEDICINE
- Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes
- (2016) Christoph Wanner et al. NEW ENGLAND JOURNAL OF MEDICINE
- Update of mortality attributable to diabetes for the IDF Diabetes Atlas: Estimates for the year 2013
- (2015) IDF Diabetes Atlas Group DIABETES RESEARCH AND CLINICAL PRACTICE
- Sodium–glucose cotransporter-2 inhibitors and blood pressure decrease
- (2015) Konstantinos P. Imprialos et al. JOURNAL OF HYPERTENSION
- Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
- (2015) Bernard Zinman et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Randomized Trial of Intensive versus Standard Blood-Pressure Control
- (2015) NEW ENGLAND JOURNAL OF MEDICINE
- Redefining Blood-Pressure Targets — SPRINT Starts the Marathon
- (2015) Vlado Perkovic et al. NEW ENGLAND JOURNAL OF MEDICINE
- Outcomes of Combined Cardiovascular Risk Factor Management Strategies in Type 2 Diabetes: The ACCORD Randomized Trial
- (2014) Karen L. Margolis et al. DIABETES CARE
- Empagliflozin Reduces Blood Pressure in Patients With Type 2 Diabetes and Hypertension
- (2014) Ilkka Tikkanen et al. DIABETES CARE
- KDOQI US Commentary on the 2012 KDIGO Clinical Practice Guideline for Management of Blood Pressure in CKD
- (2013) Sandra J. Taler et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Effect of Candesartan on Microalbuminuria and Albumin Excretion Rate in Diabetes
- (2013) Rudy Bilous ANNALS OF INTERNAL MEDICINE
- Sodium–Glucose Cotransporter 2 Inhibitors for Type 2 Diabetes
- (2013) Despoina Vasilakou et al. ANNALS OF INTERNAL MEDICINE
- 2013 ESH/ESC Practice Guidelines for the Management of Arterial Hypertension
- (2013) Giuseppe Mancia et al. BLOOD PRESSURE
- 2014 Evidence-Based Guideline for the Management of High Blood Pressure in Adults
- (2013) Paul A. James et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Sodium–glucose linked transporter-2 inhibitors: potential for renoprotection beyond blood glucose lowering?
- (2013) Richard E. Gilbert KIDNEY INTERNATIONAL
- Aggressive blood pressure reduction and renin–angiotensin system blockade in chronic kidney disease: time for re-evaluation?
- (2013) Pantelis A. Sarafidis et al. KIDNEY INTERNATIONAL
- Intensive and Standard Blood Pressure Targets in Patients With Type 2 Diabetes Mellitus
- (2012) Kerry McBrien et al. ARCHIVES OF INTERNAL MEDICINE
- Executive Summary: Standards of Medical Care in Diabetes--2013
- (2012) DIABETES CARE
- Ambulatory Blood Pressure Values in the Ongoing Telmisartan Alone and in Combination with Ramipril Global Endpoint Trial (ONTARGET)
- (2012) Giuseppe Mancia et al. HYPERTENSION
- Risk of coronary events in people with chronic kidney disease compared with those with diabetes: a population-level cohort study
- (2012) Marcello Tonelli et al. LANCET
- Blood Pressure Targets in Subjects With Type 2 Diabetes Mellitus/Impaired Fasting Glucose
- (2011) Sripal Bangalore et al. CIRCULATION
- Executive Summary: Standards of Medical Care in Diabetes--2012
- (2011) DIABETES CARE
- Effects of intensive blood pressure reduction on myocardial infarction and stroke in diabetes: a meta-analysis in 73 913 patients
- (2011) Gianpaolo Reboldi et al. JOURNAL OF HYPERTENSION
- Tight Blood Pressure Control and Cardiovascular Outcomes Among Hypertensive Patients With Diabetes and Coronary Artery Disease
- (2010) Rhonda M. Cooper-DeHoff et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies
- (2010) The Emerging Risk Factors Collaboration LANCET
- Systolic Heart Failure
- (2010) John J.V. McMurray NEW ENGLAND JOURNAL OF MEDICINE
- Effects of Medical Therapies on Retinopathy Progression in Type 2 Diabetes
- (2010) NEW ENGLAND JOURNAL OF MEDICINE
- Effects of Intensive Blood-Pressure Control in Type 2 Diabetes Mellitus
- (2010) NEW ENGLAND JOURNAL OF MEDICINE
- Effect of Lower Targets for Blood Pressure and LDL Cholesterol on Atherosclerosis in Diabetes
- (2008) Barbara V. Howard JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- The Anglo-Scandinavian Cardiac Outcomes Trial: blood pressure-lowering limb: effects in patients with type II diabetes
- (2008) Jan Östergren et al. JOURNAL OF HYPERTENSION
- Effects of different ACE inhibitor combinations on albuminuria: results of the GUARD study
- (2008) G.L. Bakris et al. KIDNEY INTERNATIONAL
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search